The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Atezolizumab + obinutuzumab + venetoclax in patients with relapsed or refractory indolent non-Hodgkin’s lymphoma (R/R iNHL): Primary analysis of a phase 2 trial from LYSA.
 
Charles Herbaux
No Relationships to Disclose
 
Herve Ghesquieres
No Relationships to Disclose
 
Reda Bouabdallah
No Relationships to Disclose
 
Stephanie Guidez
No Relationships to Disclose
 
Emmanuel Gyan
No Relationships to Disclose
 
Remi Gressin
No Relationships to Disclose
 
Nadine Morineau
No Relationships to Disclose
 
Loic Ysebaert
No Relationships to Disclose
 
Steven Le Gouill
No Relationships to Disclose
 
Camille Laurent
No Relationships to Disclose
 
Herve Tilly
Honoraria - Bristol-Myers Squibb; Roche; SERVIER
Consulting or Advisory Role - Janssen; Karyopharm Therapeutics; Roche
Travel, Accommodations, Expenses - Roche
 
Roch Houot
No Relationships to Disclose
 
Gandhi Damaj
No Relationships to Disclose
 
David Sibon
No Relationships to Disclose
 
Pierre Feugier
Honoraria - Abbvie; Amgen; Gilead Sciences; Janssen; Roche/Genentech
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Gilead Sciences; Janssen; Roche/Genentech
Speakers' Bureau - Abbvie; Amgen; Gilead Sciences; Janssen; Roche/Genentech
Research Funding - Abbvie; Amgen; Gilead Sciences; Janssen; Roche/Genentech
Travel, Accommodations, Expenses - Abbvie; Amgen; Gilead Sciences; Janssen; Roche/Genentech
 
Catherine Thieblemont
Honoraria - Abbvie; Bayer; Celgene; Gilead Sciences; Incyte; Janssen; Novartis; Roche
Research Funding - Roche
Travel, Accommodations, Expenses - Janssen-Cilag; Kite/Gilead; Novartis; Roche
 
Corinne Haioun
Honoraria - Amgen; Celgene; Gilead Sciences; Janssen-Cilag; Miltenyi Biotec; Roche; Takeda
 
Karine Tarte
No Relationships to Disclose
 
Franck Morschhauser
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Celgene; epizyme; Gilead Sciences; Roche/Genentech; SERVIER
Speakers' Bureau - Roche
Expert Testimony - Roche/Genentech
 
Guillaume Cartron
Honoraria - Abbvie; Celgene; Gilead Sciences; Janssen; Roche; Roche; Sanofi
Consulting or Advisory Role - Celgene; Roche
Travel, Accommodations, Expenses - Roche; Sanofi